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During a screening for monoclonal antibodies (MAbs) to the microsporidian Encephalitozoon hellem, three
murine hybridoma cell lines producing strong enzyme-linked immunosorbent assay (ELISA) reactivities were
cloned twice, were designated C12, E9, and Ell, and were found to secrete MAbs of the immunoglobulin M
isotype. On subsequent ELISAs, the three MAbs reacted most strongly to E. hellem, and they reacted somewhat
less to Encephalitozoon cuniculi and least to Nosema corneum, two other microsporidian species. The MAbs
produced values of absorbance against microsporidia that were at least three times greater than reactivities
obtained with control hybridoma supernatants or with uninfected host cell proteins used as antigens. By
Western blot immunodetection, the three MAbs detected three E. helkm antigens with relative molecular
weights (Mrs) of 62, 60, and 52 when assayed at the highest supernatant dilutions producing reactivity. At lower
dilutions, the MAbs detected additional proteins with Mrs of 55 and 53. By using indirect immunofluorescence
antibody staining, the MAbs, as well as hyperimmune polyclonal murine antisera raised against E. cuniculi and
E. helem, were able to detect formalin-fixed, tissue culture-derived E. cuniculi and E. heUlem and two other
human microsporidia, Enterocytozoon bieneusi and Septata intestinalis, in formalin-fixed stool and urine,
respectively. E. bieneusi, however, stained more intensely with the polyclonal antisera than with the MAbs.
Neither the MAbs nor the hyperimmune murine polyclonal antibodies detected Cryptosporidium, Giardia,
Trichomonas, or Isospora spp. At higher concentrations, the polyclonal antisera did stain N. corneum and yeast
cells. The background staining could be absorbed with Candida albicans. These results demonstrate that
polyclonal antisera to E. cuniculi and E. hellem, as well as MAbs raised against E. helkm, can be used for
indirect immunofluorescence antibody staining to detect several species of microsporidia known to cause
opportunistic infections in AIDS patients.
Microsporidia are small obligate intracellular protozoan
parasites which infect a wide range of animal hosts, including
all classes of vertebrates and most invertebrates (8). Awareness
of microsporidia is important because the number of reported
microsporidiosis cases in AIDS patients is increasing (2, 5-7,
22, 23, 29). The three most common microsporidia reported to
infect individuals with AIDS are Enterocytozoon bieneusi, En-
cephalitozoon hellem, and the Encephalitozoon-like Septata
intestinalis. E. bieneusi primarily infects small-intestinal entero-
cytes, causing diarrhea, but can also infect the biliary tract,
leading to cholangitis (4, 10, 19, 23, 26). On the other hand, E.
hellem and the Encephalitozoon-like S. intestinalis are not as
tissue specific and have been reported to cause keratoconjunc-
tivitis, sinusitis, nephritis, and enteritis (3, 15, 22, 27). Although
cases of Encephalitozoon cuniculi-associated hepatitis and peri-
tonitis in AIDS patients have been reported, it is possible that
they were actually due to the morphologically identical E.
hellem.
Presently, definitive identification of microsporidiosis de-
pends upon transmission electron microscopy, which is time-
and cost-consuming. In addition, transmission electron micros-
copy may not be sensitive enough to detect small numbers of
organisms. Serological studies for detecting microsporidium-
specific antibodies are reliable for antemortem diagnosis in
infected laboratory animals (29, 30) but may be unreliable for
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AIDS patients whose immune responses are compromised (12,
13). Mammalian microsporidium spores do stain with Gram,
Giemsa, calcofluor, and concentrated trichrome (25, 30, 32, 33,
35), but because these organisms are very small (measuring 0.5
to 2.0 ,um by 1.0 to 4.0 ,um) they are difficult to distinguish from
bacteria and small yeasts. In this article, we report the use of
polyclonal antibodies and monoclonal antibodies (MAbs) in
detecting microsporidia in formalin-fixed stool and urine by
the indirect immunofluorescence antibody test (IFAT).
MATERIALS AND METHODS
Parasites. E. hellem, E. cuniculi, and Nosema corneum were
grown in Madin-Darby canine kidney (MDCK) cells by using
RPMI 1640 supplemented with 5% fetal bovine serum, strep-
tomycin (100 ,ug/ml), penicillin (100 U/ml), amphotericin B
(0.25 ,ug/ml), and L-glutamine (2 mM) (referred to as complete
RPMI) as described previously (11, 14). Parasites from tissue
culture supernatants were centrifuged at 400 x g for 15 min,
washed once in 25 mM Tris-buffered saline (TBS; pH 7.4)
containing 0.05% Tween 20 (TBS-Tween), resuspended in
TBS, and centrifuged over 50% Percoll (Pharmacia, Piscat-
away, N.J.) at 14,000 x g for 2 min. The parasites were washed
twice with TBS to remove the Percoll and stored at 4°C in
bicarbonate buffer (pH 9.6) for use in the enzyme-linked
immunosorbent assay (ELISA) or were stored in TBS for all
other uses.
Antibodies. Murine hyperimmune antisera were obtained
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DETECTION OF MICROSPORIDIA BY IFAT 609
from female BALB/c mice (Charles River Laboratories, Wilm-
ington, Mass.) immunized intraperitoneally with four inocula-
tions of 5 x 107 spores of E. hellem, E. clinicutli, or N. corneum
at 4-week intervals. Sera were collected by tail bleeding 1 week
after each inoculation, pooled from mice within each group,
and stored at - 70°C until used. Sera from the third bleeding
were used in these studies, and the ELISA titers obtained by
assaying the sera against each homologous microsporidian
were -1: 12,800.
The E. liellem-immunized BALB/c mice used for obtaining
the polyclonal antisera were then employed for producing
MAbs. Four days after the fourth inoculation, spleen cells were
fused with the murine myeloma cell line X63.Ag8.653 (17).
Approximately 2 weeks later, and after at least three medium
changes, the supernatants were screened for antibody produc-
tion by ELISA by using intact E. hellem spores as antigens.
Positive hybridomas were cloned twice by limiting dilutions
and seeded at 105 cells per ml of complete RPMI (containing
10% fetal bovine serum) into 25-cm2 tissue culture flasks.
Three-day log-phase culture supernatants were used in the
assays described here. The MAb isotypes were determined
with the Sigma immunotype kit by following the directions
enclosed (catalog no. ISO-1; Sigma, St. Louis, Mo.).
Ascites fluid was produced in BALB/c mice by intraperito-
neal injection of 0.5 ml of pristane (2,6,10,14-tetramethylde-
canoic acid) followed by intraperitoneal injection of 10" hybri-
doma cells 2 weeks later (17). The ascites fluid was tapped
approximately 3 weeks later, centrifuged (400 x g for 15 min)
to remove cells, aliquoted, and stored at - 70°C until used.
ELISA. To perform the ELISA, E. hellem, E. cuniculi, and
N. corneum in 0.2 M bicarbonate buffer (pH 9.6) were used to
coat 96-well, flat-bottom polystyrene microtiter plates (Corn-
ing Glass Works, Corning, N.Y.) at a concentration of 5 x 107
spores per well as described by Hollister and Canning (18).
MDCK cell proteins were adjusted to 1.0 mg/ml in bicarbonate
buffer. Plates were incubated overnight at 37°C, washed with
TBS three times, and blocked with 3% (wt/vol) bovine serum
albumin (BSA) in TBS for 2 h at 37°C. After three washings
with TBS, 100 RI of the appropriate undiluted hybridoma or
control supernatant was added to each well. The plates were
incubated for 2 h at 37°C, washed three times in TBS-Tween,
and incubated for 1 h at 37°C with alkaline phosphatase-
conjugated goat anti-mouse immunoglobulin G (IgG)-IgM-
IgA (Sigma) diluted 1:4,000 in TBS containing 1% (wt/vol)
BSA (TBS-BSA). After the plates were washed three times
with TBS, 100 p.1 of the enzyme substrate p-nitrophenylphos-
phate (1.0 mg/ml of diethanolamine buffer, pH 9.6) was added,
and the optical densities were read at 405 nm on an ELISA
spectrophotometer (Dynatek Laboratories Inc., Chantilly, Va.)
(17).
SDS-PAGE and Western blotting (immunoblotting). Para-
site proteins were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) by the method of
Laemmli (20), using a 5% stacking gel, a 10 to 20% gradient
resolving gel, and diallytartardiamide as the cross-linker. Par-
asites in sample buffer containing r3-mercaptoethanol were
boiled for 5 min and centrifuged at 14,000 x g for 1 min to
remove particulate materials. Each preparative slab gel (16 by
20 cm) was loaded with 2 x 109 parasites. After electrophore-
sis, the separated polypeptides were electrophoretically trans-
ferred onto Immobilon-P membranes (Millipore, Bedford,
Mass.) and cut into strips. The strips were incubated with 5%
(wt/vol) nonfat dry milk (Carnation) in TBS for 30 min to block
unbound sites, washed in TBS-Tween for 10 min, and incu-
bated with various dilutions of each hybridoma supernatant,
positive control serum, or negative control hybridoma super-
natant. After overnight incubation the strips were washed
three times with TBS-Tween and incubated with alkaline
phosphatase-conjugated goat anti-mouse IgG-lgM (Sigma)
diluted 1:1,000 in TBS-BSA. After incubation for 60 min at
37°C, the strips were washed with three changes of TBS and
rinsed with developing buffer (50 mM Tris-HCl [pH 9.6]
containing 3 mM MgCl,) as described previously (1). Bands
were visualized by the addition of the substrates 5-bromo-4-
chloro-3-indolylphosphate (0.05 mg/ml) and nitroblue tetrazo-
lium (0.01 mg/ml) to the developing buffer. After color devel-
opment for 30 min, the strips were rinsed in distilled water,
dried, and stored in the dark.
IFAT. The IFAT was performed as described previously
(17). Thin smears were prepared on microscope slides from (i)
patient stools containing E. bieneusi fixed with buffered forma-
lin-stool (1:3, vol/vol); (ii) urine specimens containing S.
intestinalis, which were centrifuged at 400 x g for 10 min and
resuspended in 1/50 of the original volume of buffered forma-
lin; (iii) formalin-fixed tissue culture-derived E. hellem, E.
ciuniculi, or N. corneum; and (iv) nonfixed microsporidia
derived from tissue culture. The slides were air dried, fixed in
100% methanol for 5 min, and then incubated with MAbs,
polyclonal antisera, or a negative hybridoma supernatant.
After incubation in a moist chamber for 30 min at 37°C, the
slides were washed twice in TBS. Fluorescein isothiocyanate-
conjugated goat anti-mouse IgG-IgM-IgA (Sigma) was ab-
sorbed with formalin-fixed stool sediment, diluted 1:200, and
added to the slides for incubation at 37°C for 30 min. Then the
slides were washed, coverslips were added with Cytoseal
mounting medium (Stephens Scientific, Riverdale, N.J.), and
the slides were examined under UV light microscopy (Olym-
pus AH2 microscope) with an excitation wavelength of 380 to
490 nm, which generates an observation light wavelength equal
to or greater than 515 nm.
RESULTS
Characterization of MAbs by ELISA. Three hybridoma
cultures, whose supernatants reacted most strongly to E.
hellem in the ELISA, were cloned twice, designated C12, E9,
and El1, and found to secrete MAbs of the IgM isotype. The
MAbs were then tested again by ELISA using E. hellem as well
as E. cuniculi and N. corneum as antigens (Table 1). The three
MAbs reacted most strongly against E. hellem. C12 and E9 also
reacted strongly to E. cuniculli and less strongly against N.
corneum, a microsporidian isolated from the corneal stroma of
a human immunodeficiency virus-seronegative individual (9,
31). ElI produced nearly identical low levels of reactivity
against both E. cuniculi and N. corneum. In all cases, however,
the MAbs produced at least threefold-higher levels of reactiv-
ity against the microsporidia than against MDCK tissue culture
host cell proteins or against a negative hybridoma control
supernatant.
Characterization of MAbs by Western blot immunoassay.
Western blot immunodetection of E. hellem was performed to
determine the molecular weights of proteins recognized by the
MAbs. All three IgM MAbs detected proteins with MrS of 62,
60, and 50 at the highest dilutions producing reactivity. Less
diluted hybridoma supernatants also bound to proteins with
Mrs of 55 and 53 (Fig. 1). Identical results were obtained when
parasite proteins were prepared by using the protease inhibi-
tors leupeptin (0.5 ,ug/ml) and phenylmethylsulfonyl fluoride
(0.2 mM).
IFAT. Murine polyclonal antisera to E. cuniculi and E.
hellem, as well as the MAbs raised against E. hellem, were used
to detect microsporidia by IFAT. Smears of tissue culture-
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TABLE 1. ELISA reactivities of MAbs raised to E. hellema
ELISA values for absorbance to antigen target"
MAb
E. hellem E. cuniculi N. corneum MDCK cells
C12 1.153 ± 0.011 0.785 ± 0.090 0.555 ± 0.005 0.101 ± 0.006
E9 0.953 ± 0.058 0.491 ± 0.014 0.341 ± 0.070 0.094 ± 0.002
Eli 0.818 ± 0.072 0.310 ± 0.033 0.318 ± 0.043 0.052 ± 0.013
Neg. sup't. 0.104 ± 0.007 0.055 ± 0.030 0.020 ± 0.027 -0.045 ± 0.0001
a Undiluted culture supernatants from twice-cloned hybridomas were recovered and assayed as described in Materials and Methods.
b Values are the means of two replicates ± the standard deviations.
derived E. hellem, E. cuniculi, N. corneum, formalin-fixed
stools mixed with the tissue culture-derived organisms, and
stool and urine specimens with E. bieneusi and S. intestinalis,
respectively, were examined. The murine antiserum to E.
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FIG. 1. Western blot characterization of MAbs to E. hellem. E.
hellem proteins were separated by SDS-PAGE under reducing condi-
tions and transferred to Immobilon-P membranes. The membrane
antigen strips were incubated with MAbs (C12, E9, and Eli) harvested
from 3-day log-phase hybridoma cell cultures and diluted 1:10; this was
followed by immunodetection using alkaline phosphatase-conjugated
goat anti-mouse IgM and color development with nitroblue tetrazo-
lium and 5-bromo-4-chloro-3-indolylphosphate. Ascites fluid from
BALB/c mice inoculated with hybridoma E9 cells was diluted 1:100,
and the hyperimmune murine polyclonal antiserum to E. hellem (m a
E. hellem) was used at a dilution of 1:2,000. Molecular masses of
standards are given at the right (in kilodaltons). Neg. sup't., negative
supematant.
hellem (diluted 1:500) detected both native E. hellem (data not
shown) and formalin-fixed E. hellem (Fig. 2A) and E. cuniculi
(data not shown), as well as E. bieneusi (Fig. 213) and S.
intestinalis (Fig. 2C) in patient stools and urine, respectively.
The murine polyclonal antiserum to E. cuniculi produced
results identical to those obtained with the murine polyclonal
antiserum to E. hellem (data not shown). The three MAbs
producing the strongest reactivity to E. hellem in the ELISA
also detected E. hellem, E. cuniculi, E. bieneusi, and S. intesti-
nalis but not N. corneum by IFAT. Results are shown for E9
detection of E. hellem (Fig. 2D), E. bieneusi (Fig. 2E), and S.
intestinalis (Fig. 2F). IFA staining of E. bieneusi with the MAbs
(Fig. 2E) was not as strong as with the polyclonal antisera (Fig.
2B). The MAbs did not stain Cryptosporidium, Isospora, Giar-
dia, Candida, or Trichomonas spp. in known positive patient
stool specimens (data not shown). The murine hyperimmune
sera raised against E. hellem or E. cuniculi did detect N.
corneum and Candida albicans when used at dilutions of 1:200
or lower, and the nonspecific binding to yeast cells could be
reduced by absorbing with C. albicans (data not shown). In
addition, background staining, particularly when the polyclonal
antisera were used, could be further reduced by absorbing the
FIG. 2. IFAT for detecting microsporidia using polyclonal antibod-
ies and MAbs. Formalin-fixed tissue culture-derived E. hellem (A and
D), E. bieneusi in stool (B and E), and S. intestinalis in urine (C and F)
were stained with murine hyperimmune polyclonal antiserum raised
against E. hellem (A to C) or MAb E9 (D to F) as described in
Materials and Methods.
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DETECTION OF MICROSPORIDIA BY IFAT 611
fluorescein isothiocyanate-conjugated antibodies with forma-
lin-fixed stool sediment.
DISCUSSION
Opportunistic infections with microsporidia in AIDS pa-
tients are increasingly being reported, yet the number of
microsporidiosis cases is probably greatly underreported. Mi-
crosporidium infections are difficult to diagnose, primarily
because the organisms are small and difficult to distinguish
from bacteria and small yeasts in tissue and stool. Giemsa stain
(25, 32) and a modified trichrome stain using chromotrope 2R
(35) have been used to detect microsporidia in stool, but with
some difficulties. Giemsa-stained microsporidia are blue and
display a purple-blue nucleus which distinguishes them from
bacteria. It is difficult, however, to find microsporidia in stool
smears in which most other organisms also stain blue. The
modified trichrome (chromotrope 2R) staining method de-
scribed by Weber et al. (35) has the advantage that most
bacteria counterstain light green, leaving the microsporidia
pink. The stool smear must be very thin in order to observe the
internal structure of the microsporidia, so microsporidia may
be missed if the parasite burden is low or if microsporidia are
mixed with mucus. In addition, small yeasts and some bacteria
in stool also stain pink, which can complicate the results.
Finally, it is crucial to monitor the destaining step so that the
microsporidia remain pink but high background levels of
staining are not generated (16). A calcofluor staining method
utilizing Uvetix 2B (Ciba-Geigy) or fluorescent brightener
(catalog no. F-6259; Sigma) also may be useful for detecting
microsporidia (33). The microsporidia display a relatively thick
ring of fluorescence, and the anterior region appears concave.
However, because yeasts also stain with calcofluor, further
studies are needed to assess the specificity and reliability of
these stains.
The use of microsporidium-specific antibodies in IFAT
procedures appears to overcome some of these difficulties. In
earlier studies, IFAT procedures with polyclonal antisera were
used to show that several species of microsporidia demon-
strated immunological cross-reactivity (21). More recently,
polyclonal antisera produced against E. cuniculi and E. hellem
were used to diagnose ocular and systemic E. hellem infections
(27, 28), and polyclonal antiserum raised against E. cuniculi in
rabbits was used in the IFAT to detect E. bieneusi organisms in
deparaffinized tissue sections (36) and in stool (37).
In this study, we observed that polyclonal antisera raised
against E. cuniculi and E. hellem in mice, as well as the three
MAbs, detected formalin-fixed, tissue culture-derived Enceph-
alitozoon species as well as E. bieneusi in formalin-fixed stool.
The polyclonal antisera to E. cuniculi and E. hellem also
detected a newly described microsporidian, S. intestinalis (3,
24), in formalin-fixed urine. The antiserum raised against E.
cuniculi and E. hellem detected N. corneum only when used at
lower dilutions, suggesting that E. hellem and E. cuniculi are
more closely related to E. bieneusi and S. intestinalis than to N.
corneum. Unlike the polyclonal antisera raised against E.
cuniculi and E. hellem, the hybridoma supernatants did not
stain N. corneum or yeast cells in the IFAT, even though they
did react somewhat to N. corneum in the ELISA. Microspo-
ridia of the genus Nosema typically infect insects, and the lack
of cross-reactivity in the IFAT is most likely due to a lower
degree of phylogenetic relatedness (34).
The MAbs and polyclonal antibodies provided different
advantages in the IFA stain. E. bieneusi stained more intensely
with the polyclonal antisera raised against E. cuniculi or E.
hellem than with the MAbs raised against E. hellem. However,
we found that the polyclonal antisera generated more back-
ground in formalin-fixed stool specimens with the IFA stain.
The degree of background depended on the dilution of anti-
serum, as also described by Weiss et al. (36). We also found
that the polyclonal antisera stained yeast cells, but this problem
could be overcome by absorbing the antisera with C. albicans.
Neither the Candida-absorbed polyclonal antisera nor the
MAbs stained yeast cells, bacteria, or Cryptosporidium, Iso-
spora, Giardia, or Trichomonas spp.; both the antisera and
MAbs thus appeared to be specific for microsporidia. In
addition, we found that absorbing the fluorescein isothiocya-
nate-conjugated antibody with sedimented stool material
helped reduce the background staining.
That the most strongly reacting MAbs selected for cloning
were of the IgM isotype was probably due to the pentameric
structure of the IgM antibodies, which could amplify the signal
in the ELISA more than monomeric IgG MAbs could. Al-
though the three MAbs appeared to detect the same proteins
on Western blots of E. hellem, binding by E9 and E1i (but not
C12) was lost by periodate oxidation, suggesting that the
epitopes recognized by E9 and El1 are carbohydrates (unpub-
lished observations). In addition, the ELISA values for absor-
bance by the MAbs against the different microsporidia varied,
so that it is possible that the MAbs detected different epitopes
on the same proteins. The fact that several proteins were
detected by each MAb could be due to the presence of the
same epitopes on precursor molecules and/or breakdown
products in the parasite preparations used to prepare the blots.
Adding the protease inhibitors leupeptin and phenylmethylsul-
fonyl fluoride to the parasite preparations, however, still
resulted in detection of the multiple bands. Finally, it is
possible that the same epitope is found on functionally differ-
ent proteins.
The availability of polyclonal antibodies to Encephalitozoon
species and MAbs to E. hellem should be particularly useful in
screening specimens for the presence of the most common
microsporidia causing opportunistic infections in AIDS pa-
tients. Additional specimens need to be stained with these
reagents to determine their feasibility and reliability for rou-
tine diagnostic and epidemiologic studies. In addition, IgG
MAbs which, in combination, may prove more useful than IgM
MAbs are being evaluated. Most of the MAbs generated
against E. hellem were of the IgM isotype, and these MAbs
reacted more intensely than the IgG MAbs. However, we are
finding that the use of the IgM MAbs characterized in this
study may not be feasible for ELISA procedures because of
high-level, nonspecific reactivity. This may be due to the higher
level of sensitivity in ELISA than in IFA staining. Another
difficulty is that the secondary or conjugated antibodies need to
be absorbed with sedimented stool to reduce background in
the IFAT, and it may not be possible to remove this interfer-
ence for the ELISA. To reduce this background interference,
one could conjugate the MAb (e.g., with fluorescein isothio-
cyanate or alkaline phosphatase), which is easier with IgG than
with 1gM MAbs. The polyclonal antibodies and MAbs de-
scribed in this study, however, provide a basis for screening
specimens for the presence of microsporidia by IFA staining.
Species-specific diagnosis of microsporidium-positive speci-
mens should then become possible as species-specific immu-
nologic and molecular probes become available.
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